single arm:Immunotherapy

2 trials

Sponsors

Mianyang Central Hospital, Zhongshan Hospital, Fudan University

Conditions

Esophageal canceradenocarcinoma of Stomach or Esophagogastric Junction

Early Phase 1

Local radiotherapy followed by chemotherapy combined with immunotherapy for oligometastatic esophageal carcinoma

RecruitingChiCTR2100042989

Mianyang Central HospitalEsophageal cancer

Start: 2021-03-01Updated: 2021-05-17

Phase 2

Prospective Study With HIPEC and AS regimen plus PD-1 antibody in Patients With Peritoneal Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Active, not recruitingChiCTR2200060817

Zhongshan Hospital, Fudan Universityadenocarcinoma of Stomach or Esophagogastric Junction

Start: 2022-06-01Updated: 2023-03-26